Top Companies in Nuclear Medicine Equipment

The nuclear medicine equipment market is projected to reach USD 8.31 billion by 2030 from USD 6.63 billion in 2025, at a CAGR of 4.62% during the forecast period. Several key factors are driving growth in this market, including an increase in the prevalence of chronic diseases such as cancer and cardiovascular conditions, increased adoption of advanced imaging technologies such as PET/CT and SPECT/CT, and a greater emphasis on early and accurate diagnosis. Furthermore, technological advancements, expanding applications in personalized medicine, and increased global healthcare investments are all driving market growth.

Prominent players in the nuclear medicine equipment market include Hermes Medical Solutions (Sweden), DOSIsoft (France), Segami Corporation (US), GE HealthCare (US), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands). These players have incorporated various organic and inorganic growth strategies, including collaborations, acquisitions, product launches, partnerships, agreements, and expansions to strengthen their international footprint and capture a greater share in the nuclear medicine equipment market. These organic and inorganic strategies have supported the market players to expand their business footprint across geographies by offering novel nuclear medicine equipment.

• In May 2025, GE HealthCare obtained FDA 510(k) clearance for the Aurora dual-head SPECT/CT system and Clarify DL software. The system integrates functional and anatomical imaging for nuclear medicine, while the software enhances SPECT image reconstruction with deep learning technology.
• In June 2024, Hermes Medical Solutions entered into an agreement with Siemens Healthineers to offer Hermia Organ Dosimetry on the syngo.via platform. This integration will provide Siemens customers with access to Hermia’s advanced dosimetry tools via the OpenApps Digital Marketplace, enhancing personalized molecular imaging workflows.

To know about the assumptions considered for the study download the pdf brochure

GE HealthCare (US)

A global medical technology company, became an independent publicly traded entity in January 2023 following its separation from General Electric. The company operates through five main business segments, with its nuclear medicine equipment included under the Imaging segment. It combines SPECT and PET imaging systems with software platforms like Xeleris and AI-powered tools for image reconstruction and workflow support. In 2024, GE HealthCare acquired MIM Software to expand its molecular imaging and radiation oncology capabilities, which included image analysis and quantification tools used in clinical settings such as oncology, cardiology, and neurology. With over 50 manufacturing and R&D facilities, GE HealthCare serves hospitals, diagnostic centers, and research institutions in more than 160 countries.

Siemens Healthineers AG (Germany)

A prominent medical technology company, provides a wide range of products and solutions in laboratory diagnostics, healthcare IT, and diagnostic and therapeutic imaging. Its portfolio, which serves hospitals, diagnostic labs, outpatient clinics, and academic institutions globally, includes MRI, CT, PET, SPECT systems, laboratory automation technologies, and cutting-edge digital tools for clinical decision support. The company's nuclear medicine products are under the Imaging segment, specifically under Molecular Imaging, of its four primary business segments: Imaging, Diagnostics, Varian (Advanced Therapies), and Services. It is known for its high-end PET/CT and SPECT/CT systems, which include flagship products such as Biograph PET/CT and Biograph mMR PET/MR hybrids. These systems are complemented by software platforms such as MI Applications and Syngo Via, which facilitate workflow optimization, image quantification, and hybrid imaging through automation and multimodality integration. Nuclear medicine departments, oncology and cardiology clinics, and research institutions use these solutions extensively in oncology, neurology, and cardiac imaging. It has a significant global presence in the medical imaging market due to its operations in more than 70 countries and global manufacturing footprint in Europe, the Americas, and Asia Pacific.

Market Ranking

The nuclear medicine equipment market is consolidated, with major players such as Siemens Healthineers AG, GE HealthCare, and Koninklijke Philips N.V. accounting for the majority of the global market. Siemens Healthineers has a strong presence due to its diverse product portfolio of PET, SPECT, and hybrid imaging systems, as well as integrated software platforms like syngo via. GE HealthCare provides advanced SPECT and PET imaging technologies supported by proprietary software such as Xeleris and has expanded its capabilities with the acquisition of MIM Software. Philips uses its molecular imaging and healthcare informatics expertise to provide integrated PET/CT systems and clinical decision support software. Specialized vendors, such as DOSIsoft and Hermes Medical Solutions, contribute to the market by offering focused software for image processing, dosimetry, and treatment planning that address the specific needs of radiation oncology and nuclear medicine. The remaining market share is divided between regional and niche players, creating opportunities for innovation and differentiation. As clinical needs evolve, businesses prioritize interoperability, AI-enabled imaging, and workflow automation to improve precision diagnostics and streamline nuclear medicine practices.

Related Reports:

Nuclear Medicine Equipment Market by Product (Imaging: PET, SPECT, Gamma; GM Counter, Dose Calibrator), Software (Image Management, PACS, Treatment, Analytic, Workflow), Therapy (Onco, Cardio, Neuro, Ortho), End User & Region - Global Forecasts to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets Inc.
1615 South Congress Ave.
Suite 103,
Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com